Analyze patent space with the biology and evidence attached

Purna AI helps R&D and strategy teams connect claims, prior art, mechanisms, targets, assays, and competitor activity into a clearer view of novelty and freedom-to-operate risk.

Claim and prior-art mapping

Break claims into targets, modalities, mechanisms, compositions, assays, and technical constraints that can be compared.

Scientific evidence review

Review patents, papers, pathways, targets, and experimental evidence together instead of treating legal and scientific context separately.

Technical risk analysis

Highlight crowded areas, weak novelty arguments, overlapping mechanisms, missing evidence, and unexplored whitespace.

Move from patent question to evidence-backed technical analysis

Break claims into reviewable scientific components

Map targets, modalities, mechanisms, compositions, assays, and constraints so claim scope can be compared against the underlying biology.

Connect prior art to mechanisms and experiments

Review patents, papers, targets, pathways, assays, and experimental evidence together so technical risk is grounded in science.

Identify crowded areas, weak claims, and white space

Organize the landscape into risk zones so teams can see where claims overlap, where evidence is thin, and where room may remain.

Draft an editable memo for expert review

Produce a structured analysis with claim comparisons, citations, evidence tables, risk notes, and open questions for counsel or R&D review.

Start for Free